BIOCRYST PHARMACEUTICALS, INC. (BCRX) Total assets 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) total assets at each fiscal year-end, per SEC filings.
$514.2MFY2025 · since FY2016: $89.8M → $514.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $514.2M | +4.8% |
| FY2024 | $490.4M | -5.1% |
| FY2023 | $517.0M | -6.0% |
| FY2022 | $550.0M | -6.5% |
| FY2021 | $588.2M | +75.7% |
| FY2020 | $334.7M | +91.0% |
| FY2019 | $175.3M | +19.4% |
| FY2018 | $146.8M | -17.6% |
| FY2017 | $178.3M | +98.4% |
| FY2016 | $89.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCRX financial trends
BCRX RevenueBCRX Net incomeBCRX Net marginBCRX Gross profitBCRX Gross marginBCRX Operating incomeBCRX Operating marginBCRX Operating cash flowBCRX Free cash flowBCRX Capital expendituresBCRX Return on equityBCRX Stock buybacksBCRX Dividends paidBCRX Total liabilitiesBCRX Shareholders’ equityBCRX overview →